Yes, its earnings time once again, that time when everyone will go nuts over lots of numbers that in the grand scheme of things really don’t mean all that much. This is particularly true in the growing CGM market and will play out in full force when Abbott reports this Wednesday and Dexcom later in the month. No matter how many times we say it, no matter how obvious it’s becoming there are still people who think that someone is going to come along and steal the CGM thunder from Abbott and Dexcom. Well it ain’t going . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.